Marsh & McLennan Companies, Inc. (MRSH)
Marsh & McLennan: Maintaining My 'Buy' Recommendation Following Q2 Earnings
Marsh & McLennan Companies, Inc. remains a compelling long-term growth play despite recent underperformance and cyclical headwinds in the insurance sector. Q2 2026 saw resilient 6% revenue growth, driven mainly by organic initiatives, but margin pressure from rising expenses and a soft P&C pricing cycle. MRSH stock's valuation at 20x forward earnings is below its five-year average, supporting a maintained 'buy' rating as cyclical weakness overshadows solid fundamentals.
Marsh & McLennan Companies, Inc. (MRSH) Q2 2026 Earnings Call Transcript
Marsh & McLennan Companies, Inc. (MRSH) Q2 2026 Earnings Call Transcript
Marsh (MRSH) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Marsh (MRSH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marsh & McLennan Companies Q2 Earnings Call Highlights
Marsh & McLennan Companies NYSE: MRSH reported higher second-quarter revenue and earnings, with management pointing to continued demand for its risk, insurance and consulting services despite pricing pressure in commercial insurance and reinsurance markets.
Marsh (MRSH) Q2 Earnings and Revenues Top Estimates
Marsh (MRSH) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $2.72 per share a year ago.
Curious about Marsh (MRSH) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Marsh (MRSH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
Will Higher Operating Expenses Play Spoilsport for Marsh Q2 Earnings?
MRSH heads into Q2 earnings with revenue and EPS growth expected, but rising operating expenses could make another earnings beat harder to achieve.
Marsh (MRSH) Reports Next Week: Wall Street Expects Earnings Growth
Marsh (MRSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh Raises Dividend: Is Its Capital Return Story Getting Stronger?
MRSH raises its quarterly dividend 10% to 99 cents per share, highlighting strong cash generation and a continued focus on rewarding shareholders.
Can Marsh Sustain Organic Growth as Pricing Tailwinds Ease?
MRSH faces softer insurance pricing, but diversified advisory services and strong client demand could help sustain organic growth.
Marsh (MRSH) Moves 4.2% Higher: Will This Strength Last?
Marsh (MRSH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Marsh (MRSH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
